Valuation: Guided Therapeutics Inc

Market Cap 1.93Cr 1.69Cr 1.56Cr 1.46Cr 2.74Cr 182.65Cr 2.79Cr 19Cr 7.27Cr 90Cr 7.26Cr 7.1Cr 313.99Cr P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 2.22Cr 1.94Cr 1.79Cr 1.67Cr 3.15Cr 209.84Cr 3.21Cr 22Cr 8.35Cr 103.55Cr 8.34Cr 8.15Cr 360.74Cr EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 76 10/04/2006
Director/Board Member 69 10/11/2016
Director/Board Member 70 01/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
+13.33%-.--% - - 1.93Cr
-1.00%+6.82%+23.65%-3.91% 19TCr
-2.04%-1.36%-26.82%+16.30% 14TCr
-1.19%+6.43%-3.57%-20.63% 14TCr
-1.84%-6.40%-60.26%-21.09% 6.46TCr
-0.79%+4.04%+15.66%-4.10% 5.25TCr
+0.41%-0.87%-27.08%-32.38% 4.34TCr
+0.19%+4.86%+12.56%+10.46% 3.75TCr
+1.67%+4.99%+7.45%+40.71% 3.62TCr
-1.60%+0.46%-13.58%-21.21% 2.96TCr
Average +0.77%+4.47%-8.00%-3.98% 8.14TCr
Weighted average by Cap. -0.95%+5.68%-5.19%-4.03%

Financials

2024 2025
Net sales 7T 6.13T 5.66T 5.28T 9.94T 7L 10.12T 67.84T 26.34T 3L 26.3T 25.71T 11.38L 8L 7L 6L 6L 10.89L 7.25Cr 11.09L 74.34L 28.86L 3.58Cr 28.82L 28.17L 12Cr
Net income -24.17L -21.16L -19.53L -18.22L -34.32L -23Cr -34.94L -2.34Cr -90.94L -11Cr -90.81L -88.78L -39Cr -31.96L -27.97L -25.82L -24.09L -45.39L -30Cr -46.2L -3.1Cr -1.2Cr -15Cr -1.2Cr -1.17Cr -52Cr
Net Debt 17.71L 15.5L 14.31L 13.35L 25.15L 17Cr 25.6L 1.72Cr 66.64L 8.26Cr 66.54L 65.05L 29Cr 28.76L 25.17L 23.24L 21.68L 40.84L 27Cr 41.57L 2.79Cr 1.08Cr 13Cr 1.08Cr 1.06Cr 47Cr
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-